Literature DB >> 10371938

Intraoral mandibular distraction osteogenesis.

C A Guerrero1, W H Bell, G I Contasti, A M Rodríguez.   

Abstract

During recent years, distraction osteogenesis has gained in popularity for the treatment of various bone deficiencies either in the vertical, transverse, or anteroposterior dimension. Distraction osteogenesis has been shown to be an effective technique for mandibular widening and lengthening where traditional orthognathic surgery has important limitations. The intraoral approach to these procedures prevents damage to the inferior alveolar nerve and the developing dental follicles, and eliminates hypertrophic facial scars. Intraoral distraction osteogenesis also avoids donor-site morbidity, and minimizes the need for blood transfusion or prolonged fixation. This intraoral application provides for enhanced patient acceptance and reduces the potentially negative psychosocial effects of wearing an extraoral distraction appliance.

Entities:  

Mesh:

Year:  1999        PMID: 10371938     DOI: 10.1016/s1073-8746(99)80040-1

Source DB:  PubMed          Journal:  Semin Orthod        ISSN: 1073-8746            Impact factor:   0.970


  3 in total

1.  Dentate transport discs can be used to reconstruct large segmental mandibular defects.

Authors:  Mohammed E Elsalanty; Veera Malavia; Ibrahim Zakhary; Timothy Mulone; Elias D Kontogiorgos; Paul C Dechow; Lynne A Opperman
Journal:  J Oral Maxillofac Surg       Date:  2014-12-13       Impact factor: 1.895

2.  Radiographic healing patterns after tooth-borne distraction in canine model.

Authors:  Francisco Vale; Raquel Travassos; João Martins; José-Pedro Figueiredo; João-Pedro Marcelino; Inês Francisco
Journal:  J Clin Exp Dent       Date:  2021-09-01

3.  Severe unilateral scissor bite and bimaxillary protrusion treated by horseshoe Le Fort I osteotomy combined with mid-alveolar osteotomy.

Authors:  Kazuo Shimazaki; Kunihiko Otsubo; Ikuo Yonemitsu; Sachiko Kimizuka; Susumu Omura; Takashi Ono
Journal:  Angle Orthod       Date:  2013-09-25       Impact factor: 2.079

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.